Ischemic Stroke News and Research

RSS

Moderate coffee intake may support heart health, AHA says

The American Heart Association finds that habitual coffee consumption is associated with lower risks of several cardiovascular outcomes, although most evidence comes from observational studies. Moderate intake is generally safe for most adults, while energy drinks and individual caffeine sensitivity may increase cardiovascular concerns.

21 Jul 2026

Incidence of ischemic cardio-cerebrovascular disease rises among young women

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The global burden, secular trends, and future projections of ischemic cardio-cerebrovascular disease (ICCVD), a composite indicator of ischemic heart disease (IHD) and ischemic stroke (IS), have not been specifically described in women.

15 Jul 2026

Ultrasound therapy improves poststroke motor coordination in mouse model

Following stroke, patients have a hard time performing coordinated movements. Transcranial ultrasound stimulation (TUS) is emerging as a treatment to improve poststroke coordination, but the mechanisms for this motor improvement remain unclear.

22 Jun 2026

Blood pressure control may be the key to optimizing stroke treatment after thrombectomy

Blood pressure management after thrombectomy for acute ischemic stroke may require a change in approach.

11 Jun 2026

AI digital twins may improve bilingual aphasia rehabilitation

According to the National Aphasia Association, about 2 million U.S. citizens live with aphasia, but only two-thirds of Americans are aware of the condition, which is a communication disorder that often occurs after a stroke.

9 Jun 2026

Acupuncture improves stroke recovery and reshapes brain networks

Acupuncture shows promise for stroke recovery, promoting neuroplasticity and motor function improvements, according to findings from a randomized MRI trial.

8 Jun 2026

Migraine with aura linked to higher ischemic stroke risk in middle-aged and older adults

Migraine with aura was associated with an increased risk of ischemic stroke in middle-aged and older people, according to a study published May 20, 2026, in Neurology Open Access, an official journal of the American Academy of Neurology.

20 May 2026

Silent heart attacks may speed cognitive decline

Research shows hidden heart attacks accelerate cognitive decline, highlighting the need for better identification of cardiovascular risks to brain health.

18 May 2026

Research identifies significant spike in neurological disorders during the covid-19 pandemic

In 2021, neurological diseases affected 3.40 billion individuals worldwide, corresponding to 43.1 % of the global population. In China, rapid demographic shifts and lifestyle changes have contributed to a continued rise in the burden of stroke, dementia, and Parkinson's disease-a trend expected to persist.

15 May 2026

Brain artery widening may drive lacunar stroke more than artery narrowing

Abnormal brain artery widening is associated with lacunar stroke, indicating a shift in understanding the mechanisms behind small vessel disease in the brain.

11 May 2026

AI-powered MRI scans predict diabetes and heart disease risk

Research shows AI-enhanced MRI body composition metrics can predict diabetes and heart disease risks, offering insights for better health screening practices.

8 May 2026

Research links muscle loss, weaker grip and slower walking pace to higher risk of stroke

Muscle loss, a weaker grip and a slower walking pace were associated with a higher risk of stroke in adults, according to new research published today in Stroke, the peer-reviewed scientific journal of the American Stroke Association, a division of the American Heart Association.

7 May 2026

AHA calls for lifelong brain health strategy to prevent cognitive decline

The AHA scientific statement calls for a life-course approach to brain health that integrates cognitive, emotional, behavioral, vascular, environmental, inflammatory, sleep, microbiome, and social factors. It highlights how early-life exposures, mental health, pollution, chronic inflammation, poor sleep, gut dysbiosis, and socioeconomic adversity may shape brain resilience and later-life cognitive decline.

29 Apr 2026

Tirzepatide significantly reduces cardiovascular risk in high-risk patients

Two new studies show that tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist (RA), significantly reduces cardiovascular risk in high-risk patients, including those undergoing percutaneous coronary intervention (PCI) and those with obesity undergoing transcatheter aortic valve replacement (TAVR).

23 Apr 2026

Severe strokes significantly increase the risk of progressive dementia

As stroke severity increases, the risk of progressive cognitive decline and dementia substantially escalates, according to a national study led by Michigan Medicine researchers.

23 Apr 2026

More steps cut chronic disease risk but cannot fully undo long sitting

Research shows higher daily step counts can mitigate risks of chronic diseases linked to prolonged sitting, emphasizing the need to reduce sedentary time.

10 Apr 2026

Evolocumab trial could reshape how doctors treat high-risk cholesterol patients

A new ACC/AHA dyslipidemia guideline and editorial argue that guideline development is rigorous but can lag behind fast-moving science, using the VESALIUS-CV trial as a clear example. The trial showed that intensive LDL cholesterol lowering with evolocumab reduced cardiovascular events in high-risk patients without prior heart attack or stroke, with implications for future guideline updates.

6 Apr 2026

Low birthweight increases stroke risk independent of adult BMI

In new research to be presented at this year's European Congress on Obesity (ECO2026) in Istanbul, Turkey (12-15 May), researchers show an increased risk of stroke in young adulthood for children of low birthweight, independent of their body mass index (BMI) as young adults or gestational age at birth.

3 Apr 2026

Evolocumab reduces cardiac events in high-risk diabetic patients

The cholesterol-lowering therapy evolocumab reduced the risk of major adverse cardiac events by nearly one-third among patients who had no known significant atherosclerosis and had diabetes, according to a study presented at the American College of Cardiology's Annual Scientific Session.

28 Mar 2026

Intensive cholesterol‑lowering therapy reduces first major cardiac event in high‑risk patients with diabetes

Mass General Brigham researchers found that the intensive cholesterol‑lowering therapy evolocumab reduced the risk of a first major cardiovascular event in high‑risk patients who did not have known atherosclerosis (the build-up of plaque inside artery walls) but did have diabetes.

28 Mar 2026